Total Payments
$3,438
2024 Payments
$984.68
Companies
32
Transactions
211
Medicare Patients
2,710
Medicare Billing
$253,548
Payment Breakdown by Category
Food & Beverage$3,438 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,438 | 211 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $584.43 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $520.98 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $364.46 | 22 | $0 (2024) |
| Amgen Inc. | $178.07 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $155.52 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $150.96 | 7 | $0 (2023) |
| Novo Nordisk Inc | $136.16 | 8 | $0 (2024) |
| Lilly USA, LLC | $135.24 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $114.41 | 7 | $0 (2024) |
| Ultragenyx Pharmaceutical Inc. | $110.21 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $984.68 | 52 | AstraZeneca Pharmaceuticals LP ($169.51) |
| 2023 | $778.86 | 41 | ABBVIE INC. ($116.84) |
| 2022 | $823.73 | 55 | ABBVIE INC. ($174.36) |
| 2021 | $850.70 | 63 | AbbVie Inc. ($220.34) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.09 | General |
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Gastroenterology | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: PAIN | ||||||
| 09/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Endocrinology | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Biological | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Oncology | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 656 | 967 | $153,016 | $61,739 |
| 2022 | 7 | 733 | 1,115 | $156,584 | $66,159 |
| 2021 | 9 | 663 | 1,087 | $153,467 | $70,654 |
| 2020 | 9 | 658 | 1,173 | $147,837 | $54,996 |
Total Patients
2,710
Total Services
4,342
Medicare Billing
$253,548
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 261 | 481 | $83,629 | $31,875 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 138 | 138 | $29,306 | $14,632 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 190 | $23,856 | $9,590 | 40.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $4,327 | $1,992 | 46.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 13 | $3,564 | $1,738 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $5,791 | $1,224 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,688 | $513.31 | 30.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 30 | 36 | $475.00 | $122.76 | 25.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 60 | $380.00 | $52.15 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 307 | 559 | $86,086 | $37,657 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 141 | 141 | $36,660 | $15,238 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 184 | 247 | $26,676 | $11,429 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $5,174 | $1,452 | 28.1% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 16 | 17 | $850.00 | $163.79 | 19.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 43 | 47 | $470.00 | $162.02 | 34.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 16 | 78 | $668.22 | $56.97 | 8.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 325 | 646 | $98,290 | $46,408 | 47.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 119 | 119 | $30,247 | $13,034 | 43.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 145 | $15,432 | $7,042 | 45.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $4,712 | $1,899 | 40.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 12 | 13 | $2,631 | $1,785 | 67.9% |
| 69209 | Removal of impacted ear wax by washing | Office | 2021 | 14 | 15 | $750.00 | $177.12 | 23.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 20 | 20 | $670.00 | $147.90 | 22.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 22 | 23 | $230.00 | $80.04 | 34.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 19 | 85 | $505.00 | $80.00 | 15.8% |
About Roxanne Rea, PA-C
Roxanne Rea, PA-C is a Medical healthcare provider based in Gold Canyon, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1104177096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Roxanne Rea, PA-C has received a total of $3,438 in payments from pharmaceutical and medical device companies, with $984.68 received in 2024. These payments were reported across 211 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,438).
As a Medicare-enrolled provider, Rea has provided services to 2,710 Medicare beneficiaries, totaling 4,342 services with total Medicare billing of $253,548. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Gold Canyon, AZ
- Active Since 10/02/2012
- Last Updated 03/28/2024
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1104177096
Products in Payments
- TRELEGY ELLIPTA (Drug) $335.22
- FARXIGA (Drug) $284.08
- UBRELVY (Drug) $256.79
- QULIPTA (Drug) $153.21
- JARDIANCE (Drug) $151.09
- ENTRESTO (Drug) $150.96
- BREZTRI (Drug) $140.44
- XIFAXAN (Drug) $114.41
- Cologuard Collection Kit (Device) $107.97
- Otezla (Drug) $99.48
- AIRSUPRA (Drug) $96.46
- Ozempic (Drug) $91.58
- SYNTHROID (Drug) $90.56
- EVENITY (Biological) $78.59
- Dexcom G6 Transmitter (Medical Supply) $67.89
- MOUNJARO (Drug) $62.94
- VRAYLAR (Drug) $60.52
- GEMTESA (Drug) $56.72
- Crysvita (Drug) $49.11
- FREESTYLE LIBRE 2 (Device) $46.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.